Hainan Shuangcheng Pharmaceuticals: Announcement of the resolution of the 12th meeting of the 5th board of directors of Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Announcement of the Release of Pledged Shares by Shareholders of Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Notice of Hainan Shuangcheng Pharmaceuticals Limited's First Extraordinary General Meeting of Shareholders in 2024.
Hainan Shuangcheng Pharmaceuticals: Announcement of the resolution of the 11th meeting of the fifth board of supervisors of Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceuticals Co., Ltd. regarding the provision of financial assistance to its holding subsidiary and related transactions.
Hainan Shuangcheng Pharmaceuticals: Announcement on the release of shareholder's pledge by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Announcement on Changes to Pharmaceutical Manufacturing License of Subsidiary Controlled by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Announcement on Changes to Pharmaceutical Manufacturing License of Subsidiary Controlled by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on the repurchase and cancellation of some restricted shares, reduction of registered capital and notification to creditors
Hainan Shuangcheng Pharmaceuticals: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Hainan Shuangcheng Pharmaceutical Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Legal Opinion of Beijing Zhonglun Law Firm on the 2023 Annual General Meeting of Shareholders of Hainan Shuangcheng Pharmaceutical Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on the holding subsidiary passing the GMP compliance inspection
Hainan Shuangcheng Pharmaceuticals: 002693 Shuangcheng Pharmaceutical Investor Relations Management Information 20240514
Hainan Shuangcheng Pharmaceuticals: 002693 Shuangcheng Pharmaceutical Investor Relations Management Information 20240513
Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on the completion of cancellation of some stock options in the 2021 Stock Options and Restricted Stock Incentive Plan
Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on the US FDA approval for octreotide acetate injection ANDA
Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on participating in the 2023 Hainan Listed Company Performance Briefing and Investor Group Reception Day
Hainan Shuangcheng Pharmaceuticals: Hainan Shuangcheng Pharmaceutical Co., Ltd. 2023 Financial Results Report
Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on the 2021 Stock Options and Restricted Stock Incentive Plan for the repurchase and cancellation of some of the incentive recipients of restricted stocks that have been granted but sales restrictions have not yet been lifted
Hainan Shuangcheng Pharmaceuticals: Report on the work of the 2023 Supervisory Committee of Hainan Shuangcheng Pharmaceutical Co., Ltd.
No Data